BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25772157)

  • 1. Integrase interactor 1 in health and disease.
    Das S
    Curr Protein Pept Sci; 2015; 16(6):478-90. PubMed ID: 25772157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrase interactor 1 (Ini1/hSNF5) is a repressor of basal human immunodeficiency virus type 1 promoter activity.
    Boese A; Sommer P; Holzer D; Maier R; Nehrbass U
    J Gen Virol; 2009 Oct; 90(Pt 10):2503-2512. PubMed ID: 19515827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of DNA binding property of the HIV-1 host factor and tumor suppressor protein Integrase Interactor 1 (INI1/hSNF5).
    Das S; Banerjee B; Hossain M; Thangamuniyandi M; Dasgupta S; Chongdar N; Kumar GS; Basu G
    PLoS One; 2013; 8(7):e66581. PubMed ID: 23861745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aurora A is a repressed effector target of the chromatin remodeling protein INI1/hSNF5 required for rhabdoid tumor cell survival.
    Lee S; Cimica V; Ramachandra N; Zagzag D; Kalpana GV
    Cancer Res; 2011 May; 71(9):3225-35. PubMed ID: 21521802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SNF5 reexpression in malignant rhabdoid tumors regulates transcription of target genes by recruitment of SWI/SNF complexes and RNAPII to the transcription start site of their promoters.
    Kuwahara Y; Wei D; Durand J; Weissman BE
    Mol Cancer Res; 2013 Mar; 11(3):251-60. PubMed ID: 23364536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The requirement for SNF5/INI1 in adipocyte differentiation highlights new features of malignant rhabdoid tumors.
    Caramel J; Medjkane S; Quignon F; Delattre O
    Oncogene; 2008 Mar; 27(14):2035-44. PubMed ID: 17922027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of INI1/hSNF5 in gene regulation and cancer.
    Stojanova A; Penn LZ
    Biochem Cell Biol; 2009 Feb; 87(1):163-77. PubMed ID: 19234532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RhoA-dependent regulation of cell migration by the tumor suppressor hSNF5/INI1.
    Caramel J; Quignon F; Delattre O
    Cancer Res; 2008 Aug; 68(15):6154-61. PubMed ID: 18676838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human SNF5/INI1, a component of the human SWI/SNF chromatin remodeling complex, promotes nucleotide excision repair by influencing ATM recruitment and downstream H2AX phosphorylation.
    Ray A; Mir SN; Wani G; Zhao Q; Battu A; Zhu Q; Wang QE; Wani AA
    Mol Cell Biol; 2009 Dec; 29(23):6206-19. PubMed ID: 19805520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative molecular genetic analysis of simian and human HIV-1 integrase interactor INI1/SMARCB1/SNF5.
    Pyeon D; Price L; Park IW
    Arch Virol; 2015 Dec; 160(12):3085-91. PubMed ID: 26350979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The integrase interactor 1 (INI1) proteins facilitate Tat-mediated human immunodeficiency virus type 1 transcription.
    Ariumi Y; Serhan F; Turelli P; Telenti A; Trono D
    Retrovirology; 2006 Aug; 3():47. PubMed ID: 16889668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus nuclear protein 2 (EBNA2) binds to a component of the human SNF-SWI complex, hSNF5/Ini1.
    Wu DY; Kalpana GV; Goff SP; Schubach WH
    J Virol; 1996 Sep; 70(9):6020-8. PubMed ID: 8709224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. INI1/hSNF5-interaction defective HIV-1 IN mutants exhibit impaired particle morphology, reverse transcription and integration in vivo.
    Mathew S; Nguyen M; Wu X; Pal A; Shah VB; Prasad VR; Aiken C; Kalpana GV
    Retrovirology; 2013 Jun; 10():66. PubMed ID: 23799881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [BEX2 regulates cell cycle through the interaction with INI1/hSNF5].
    Han QY; Fan YH; Wang YL; Zhang SD; Han CY
    Yi Chuan; 2012 Jun; 34(6):711-8. PubMed ID: 22698742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell cycle arrest and repression of cyclin D1 transcription by INI1/hSNF5.
    Zhang ZK; Davies KP; Allen J; Zhu L; Pestell RG; Zagzag D; Kalpana GV
    Mol Cell Biol; 2002 Aug; 22(16):5975-88. PubMed ID: 12138206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity of interaction of INI1/hSNF5 with retroviral integrases and its functional significance.
    Yung E; Sorin M; Wang EJ; Perumal S; Ott D; Kalpana GV
    J Virol; 2004 Mar; 78(5):2222-31. PubMed ID: 14963118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoplasmic interaction of the tumour suppressor protein hSNF5 with dynamin-2 controls endocytosis.
    Alfonso-Pérez T; Domínguez-Sánchez MS; García-Domínguez M; Reyes JC
    Oncogene; 2014 Jun; 33(23):3064-74. PubMed ID: 23851497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A key role of the hSNF5/INI1 tumour suppressor in the control of the G1-S transition of the cell cycle.
    Versteege I; Medjkane S; Rouillard D; Delattre O
    Oncogene; 2002 Sep; 21(42):6403-12. PubMed ID: 12226744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and functional role of INI1 and LEDGF in the HIV-1 preintegration complex.
    Maillot B; Lévy N; Eiler S; Crucifix C; Granger F; Richert L; Didier P; Godet J; Pradeau-Aubreton K; Emiliani S; Nazabal A; Lesbats P; Parissi V; Mely Y; Moras D; Schultz P; Ruff M
    PLoS One; 2013; 8(4):e60734. PubMed ID: 23593299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromatin-remodeling factor INI1/hSNF5/BAF47 is involved in activation of the colony stimulating factor 1 promoter.
    Pan X; Song Z; Zhai L; Li X; Zeng X
    Mol Cells; 2005 Oct; 20(2):183-8. PubMed ID: 16267391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.